Form:
Eye Drops
Concentration:
0.005%
Pack:
2.5 ml
Composition:
latanoprost
– Eye drops.
– Reducing elevated intraocular pressure in conditions such as ocular hypertension and chronic open-angle glaucoma.
– Works by increasing aqueous humor fluid uveoscleral outflow by 50%.
– Maintains a 24 hour consistent IOP control.
– The first-line therapy for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension approved US FDA.
– One drop in the affected eye(s) once a day.
Amman Pharmaceutical Industries (API) was established in 1989 as one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of Ophthalmology, ENT (Ear, Nose & Throat ) , respiratory, and Dermatology. After many years of success.
